Patents by Inventor Colin R. Dunstan

Colin R. Dunstan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPG FUSION PROTEIN COMPOSITIONS AND METHODS
    Publication number: 20030144187
    Abstract: The present invention relates to OPG fusion protein compositions, methods of preparation of such compositions and uses thereof. More particularly, the present invention relates to a fusion protein comprising an OPG polypeptide and an immunoglobulin FC region.
    Type: Application
    Filed: September 3, 1999
    Publication date: July 31, 2003
    Inventors: COLIN R. DUNSTAN, SCOTT K.. WOODEN, MICHAEL B. MANN
  • Use of fibroblast growth factors to stimulate bone growth
    Patent number: 5656598
    Abstract: The present invention provides therapeutic compositions for the prevention and treatment of pathological conditions involving bone and dental tissue. The present invention also provides a method to promote bone repair and/or growth for the treatment of pathological conditions involving bone tissue, for example, osteoporosis, Paget's disease, osteopetrosis, and periodontal disease and fracture repair, and healing of bone defects by administering FGF-1 to an animal or human in need of such treatment.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: August 12, 1997
    Assignees: Rhone-Poulenc Rorer Pharmaceuticals Inc., Osteosa Inc.
    Inventors: Colin R. Dunstan, Elzbieta Izbicka, Gregory R. Mundy, Wilson Burgess, Michael C. Jaye
  • Use of fibroblast growth factors to stimulate bone growth
    Patent number: 5614496
    Abstract: The present invention provides therapeutic compositions for the prevention and treatment of pathological conditions involving bone and dental tissue. The present invention also provides a method to promote bone repair and/or growth for the treatment of pathological conditions involving bone tissue, for example, osteoporosis, Paget's disease, osteopetrosis, and periodontal disease and fracture repair, and healing of bone defects by administering FGF-1 to an animal or human in need of treatment.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: March 25, 1997
    Assignees: OsteoSA Inc., Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: Colin R. Dunstan, Elzbieta Izbicka, Gregory R. Mundy, Wilson Burgess, Michael C. Jaye